Journal of medicinal chemistry · 1998
Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taverne T, Diouf O, Depreux P, Poupaert J H, Lesieur D, Guardiola-Lemaître B, Renard P, Rettori M C, Caignard D H, Pfeiffer B
Аннотация
Since it was known that 5HT properties (5HT1A agonism or 5HT2A antagonism) combined with D2 antagonism may lead to atypical antipsychotic drugs, a series of 19 benzothiazolin-2-one and benzoxazin-3-one derivatives possessing the arylpiperazine moiety was prepared, and their binding profiles were investigated. All tested compounds displayed very high affinities for the 5HT1A and D2 receptors. Therefore, further pharmacological studies were carried out on selected compounds (24, 27, 30, 46, and 47). This evaluation in rats clearly revealed potent antipsychotic properties along with a decrease of extrapyramidal side effects. These derivatives are currently under preclinical development.
Предметные рубрики MeSH
AnimalsAntipsychotic AgentsAvoidance LearningCatalepsyCattleCorpus StriatumDopamine AgentsFrontal LobeHippocampusHyperkinesisMiceOxazinesPiperazinesRabbitsRatsRats, WistarReceptors, Dopamine D2Receptors, SerotoninReceptors, Serotonin, 5-HT1Serotonin AgentsSleepStereotyped BehaviorStructure-Activity RelationshipSwineThiazoles